Siprofloksasin katılmış kemik çimentosunun biyomekanik özellikleri

Yıl 2013, Cilt: 47 Sayı: 1, 55 - 59, 06.04.2013

Talip Aslan Zekeriya Oztemur Mahmut Cifci Gunduz Tezeren Hayati Ozturk Okay Bulut

Öz

Amaç: Bu çalışmanın amacı eklem replasman cerrahisinde kullanılan siprofloksasin eklenmiş kemik çimentosunun biyomekanik özelliklerini araştırmaktı.
Çalışma planı: İlk grup (kontrol grubu) sadece çimento, diğer 4 grup, sırasıyla, 500 mg, 1000 mg, 1500 mg ve 2000 mg siprofloksasin eklenmiş 40 g kemik çimentosu içermekte idi. Aksiyel kompresyon testleri 50.000 Newton kapasiteli basma-çekme test cihazı ile yapıldı.
Bulgular: Kontrol grubunun aksiyel dayanımı 80.2±4.3 MPa iken, siprofloksasin verilen gruplarda bu değer dozların arttırıldığı grup sıralamasına göre 74.5±5.4 MPa, 70.6±4.8 MPa, 70.5±4.7 MPa ve 69.3±3.4 MPa olarak bulundu.
Çıkarımlar: Kemik çimentosuna 500 ila 1500 mg siprofloksasin eklenmesi Amerikan Test ve Malzeme Cemiyeti’nin tavsiye ettiği değer olan 70.0 MPa’nın üzerinde mekanik aksiyel dayanım sağlamaktadır ve bu özelliğiyle eklem replasman cerrahisinde güvenle kullanılabilir.

Anahtar Kelimeler

Aksiyel kompresyon; kemik çimentosu; PMMA; siprofloksasin

Biomechanical properties of ciprofloxacin loaded bone cement

Öz

Objective: The purpose of this study was to investigate the biomechanical properties of bone cement used in joint replacement surgery after the addition of ciprofloxacin.
Methods: The first group received bone cement only and served as a control for the 4 groups where 500 mg, 1000 mg, 1500 mg and 2000 mg of ciprofloxacin were added to yield 40 g of bone cement. Axial compression tests were conducted using a 50,000 Newton capacity tension-compression testing device.
Results: While axial compression strength at failure was 80.2±4.3 MPa in the control group, values in the ciprofloxacin-treated groups decreased with rising concentration of ciprofloxacin to 74.5±5.4 MPa, 70.6±4.8 MPa, 70.5±4.7 MPa, and 69.3±3.4 MPa.
Conclusion: Bone cement with addition of 500 to 1500 mg ciprofloxacin maintained mechanical axial strength values above 70.0 MPa recommended by American Society for Testing and Materials and can be safely used in joint replacement surgery.

Anahtar Kelimeler

Axial compression, bone cement, ciprofloxacin, PMMA

Kaynakça

• Yonekura Y, Miyamoto H, Shimazaki T, Ando Y, Noda I, Mawatari M, et al. Osteoconductivity of thermal-sprayed silver-containing hydroxyapatite coating in the rat tibia. J Bone Joint Surg Br 2011;93:644-9.
• Vercillo M, Patzakis MJ, Holtom P, Zalavras CG. Linezolid in the treatment of implant-related chronic osteomyelitis. Clin Orthop Relat Res 2007;461:40-3.
• Senthi S, Munro JT, Pitto RP. Infection in total hip replacement: meta-analysis. Int Orthop 2011;35:253-60.
• Buchholz HW, Engelbrecht H. Depot effects of various antibiotics mixed with Palacos resins. [Article in German] Chirurg 1970;41:511-5.
• Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am 2006;88:2487-500.
• Mader JT, Calhoun J, Cobos J. In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmethacrylate beads. Antimicrob Agents Chemother 1997;41:415-8.
• Mohd Fuad D, Masbah O, Shahril Y, Jamari S, Norhamdan MY, Sahrim SH. Biomechanical properties of bone cement with addition of cefuroxime antibiotic. Med J Malaysia 2006; 61 Suppl A:27-9.
• Tuncay I, Ozbek H, Köflem M, Unal O. A comparison of effects of fluoroquinolones on fracture healing (an experimental study in rats). Ulus Travma Acil Cerrahi Derg 2005;11:17-22.
• Tunney MM, Ramage G, Patrick S, Nixon JR, Murphy PG, Gorman SP. Antimicrobial susceptibility of bacteria isolated from orthopedic implants following revision hip surgery. Antimicrob Agents Chemother 1998;42:3002-5.
• Engesæter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003;74:644-51.
• Baleani M, Persson C, Zolezzi C, Andollina A, Borrelli AM, Tigani D. Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty 2008; 23:1232-8.
• Walenkamp GH. Gentamicin PMMA beads and other local antibiotic carriers in two-stage revision of total knee infection: a review. J Chemother 2001;13 Spec No 1:66-72.
• Senthi S, Munro JT, Pitto RP. Infection in total hip replacement: meta-analysis. Int Orthop 2011;35:253-60.
• Anguita-Alonso P, Rouse MS, Piper KE, Jacofsky DJ, Osmon DR, Patel R. Comparative study of antimicrobial release kinetics from polymethylmethacrylate. Clin Orthop Relat Res 2006;445:239-44.
• Ismael F, Bléton R, Saleh-Mghir A, Dautrey S, Massias L, Crémieux AC. Teicoplanin-containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infection. Antimicrob Agents Chemother 2003;47: 3365-7.
• Buchholz HW, Elson RA, Heinert K. Antibiotic-loaded acrylic cement: current concepts. Clin Orthop Relat Res 1984; (190):96-108.
• Gö¤üfl A, Akman S, Göksan SB, Bozda¤ E. Mechanical strength of antibiotic-impregnated bone cement on Day 0 and Day 15: a biomechanical study with Surgical Simplex P and teicoplanin. [Article in Turkish] Acta Orthop Traumatol Turc 2002;36:63-71.
• DiMarcantonio T. Aggressive debridement recommended for acute infections after knee replacement. Orthopedics Today 2007;27:10-11.
• Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998;279: 1537Adams K, Couch L, Cierny G, Caloun J, Mader JT. In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop Relat Res 1992:(278):244-52.
• DiMaio FR, O’Halloran JJ, Quale JM. In vitro elution of ciprofloxacin from polymethylmethacrylate cement beads. J Orthop Res 1994;(12):79-82.
• Huddleston PM, Steckelberg JM, Hanssen AD, Rouse MS, Bolander ME, Patel R. Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am 2000;82:161-73.
• Antoci V Jr, Adams CS, Hickok NJ, Shapiro IM, Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin Orthop Relat Res 2007;462:200-6.
• Tsourvakas S, Alexandropoulos C, Karatzios C, Egnatiadis N, Kampagiannis N. Elution of ciprofloxacin from acrylic bone cement and fibrin clot: an in vitro study. Acta Orthop Belg 2009;75:537-42.
• Stahlmann R, Lode H. Toxicity of quinolones. Drugs 1999;58 Suppl 2:37-42.
• Hayem G, Carbon C. A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects. Drug Saf 1995;13:338-42.
• Herbold BA, Brendler-Schwaab SY, Ahr HJ. Ciprofloxacin: in vivo genotoxicity studies. Mutat Res 2001;498:193-205.
• Demirel H. Mechanical endurance of bone cement with antibiotics prepared with a different method: biomechanical study performed with teicoplanin. Master’s thesis, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey: 2004.